<ol class="cite-this-references"><li id="reference-A912">Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006 Jun 3;332(7553):1302-8. [<a href="/articles/A912" target="_blank">Article</a>] </li><li id="reference-A913">Solomon DH, Avorn J, Sturmer T, Glynn RJ, Mogun H, Schneeweiss S: Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 May;54(5):1378-89. [<a href="/articles/A913" target="_blank">Article</a>] </li><li id="reference-A914">FitzGerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001 Aug 9;345(6):433-42. [<a href="/articles/A914" target="_blank">Article</a>] </li><li id="reference-A915">Graham DJ: COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA. 2006 Oct 4;296(13):1653-6. Epub 2006 Sep 12. [<a href="/articles/A915" target="_blank">Article</a>] </li><li id="reference-A916">Brater DC: Renal effects of cyclooxygyenase-2-selective inhibitors. J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S15-20; discussion S21-3. [<a href="/articles/A916" target="_blank">Article</a>] </li><li id="reference-A917">Gan TJ: Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010 Jul;26(7):1715-31. doi: 10.1185/03007995.2010.486301. [<a href="/articles/A917" target="_blank">Article</a>] </li><li id="reference-A178633">Davies NM, Anderson KE: Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003. [<a href="/articles/A178633" target="_blank">Article</a>] </li><li id="reference-A180694">Todd PA, Sorkin EM: Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004. [<a href="/articles/A180694" target="_blank">Article</a>] </li><li id="reference-A31847">Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 2005 Jul;33(7):1027-35. doi: 10.1124/dmd.104.002527. Epub 2005 Apr 20. [<a href="/articles/A31847" target="_blank">Article</a>] </li><li id="reference-A179023">Chen L, Yang G, Grosser T: Prostanoids and inflammatory pain. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:58-66. doi: 10.1016/j.prostaglandins.2012.08.006. Epub 2012 Sep 3. [<a href="/articles/A179023" target="_blank">Article</a>] </li><li id="reference-A179044">Hirata T, Narumiya S: Prostanoids as regulators of innate and adaptive immunity. Adv Immunol. 2012;116:143-74. doi: 10.1016/B978-0-12-394300-2.00005-3. [<a href="/articles/A179044" target="_blank">Article</a>] </li><li id="reference-A180796">Sallmann AR: The history of diclofenac. Am. J. Med. 1986 Apr 28;80(4):29-33. [<a href="/articles/A180796" target="_blank">Article</a>] </li><li id="reference-A31196">Bort R, Mace K, Boobis A, Gomez-Lechon MJ, Pfeifer A, Castell J: Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96. [<a href="/articles/A31196" target="_blank">Article</a>] </li><li id="reference-A181015">Yan Z, Li J, Huebert N, Caldwell GW, Du Y, Zhong H: Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides. Drug Metab Dispos. 2005 Jun;33(6):706-13. doi: 10.1124/dmd.104.003095. Epub 2005 Mar 11. [<a href="/articles/A181015" target="_blank">Article</a>] </li><li id="reference-A181018">Boerma JS, Vermeulen NP, Commandeur JN: One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac. Chem Biol Interact. 2014 Jan 25;207:32-40. doi: 10.1016/j.cbi.2013.11.001. Epub 2013 Nov 15. [<a href="/articles/A181018" target="_blank">Article</a>] </li><li id="reference-A181021">Kamimura H, Ito S, Nozawa K, Nakamura S, Chijiwa H, Nagatsuka S, Kuronuma M, Ohnishi Y, Suemizu H, Ninomiya S: Formation of the accumulative human metabolite and human-specific glutathione conjugate of diclofenac in TK-NOG chimeric mice with humanized livers. Drug Metab Dispos. 2015 Mar;43(3):309-16. doi: 10.1124/dmd.114.061689. Epub 2014 Dec 11. [<a href="/articles/A181021" target="_blank">Article</a>] </li><li id="reference-T116">Brunton LL, Hilal-Dandan R, Knollmann BC. eds (2018). Goodman &amp; Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education. [<a href="https://www.google.com/search?tbo=p&amp;tbm=bks&amp;q=978-1-25-958473-2" rel="noopener" target="_blank">ISBN:978-1-25-958473-2</a>] </li><li id="reference-L7360">Drugs@FDA: Voltaren Delayed Release [<a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=019201" target="_blank">Link</a>] </li><li id="reference-L12693">Health Canada Product Monograph: Diclofenac oral tablets [<a href="https://pdf.hres.ca/dpd_pm/00054964.PDF" target="_blank">Link</a>] </li></ol>